Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"610"
topic_facet:"Leukemia"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22610%22&filter%5B%5D=topic_facet%3A%22Leukemia%22&lookfor=%22Myeloma%22&type=Subject
PubPharm (317)
1
VOB560-MIK665 Combination First in Human Trial in Patients With Hematological Malignancies (Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma) : A Phase Ib, Multicenter Study of VOB560 in Combination With MIK665 in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma, Relapsed/Refractory Acute Myeloid Leukemia, or Relapsed/Refractory Multiple Myeloma.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer : A Phase Ib Study to Evaluate Safety and Persistence of ex Vivo Expanded Universal Donor NK Cells in Combination With IL-2 and TGFbeta Receptor I Inhibitor Vactosertib in Patients With Locally Advanced/Metastatic Colorectal Cancer and Relapsed/Refractory Hematologic Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) : A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma : Expression of the Genome in Lymphoid Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Personalized NK Cell Therapy in CBT : Personalized NK Cell Therapy in CBT
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Biomarker for Infection Risk in CLL and MM : Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Natural Killer Cells and Bortezomib to Treat Cancer : Safety and the Anti- Tumor Effects of Escalating Doses of Adoptively Infused Ex Vivo Expanded Autologous Natural Killer (NK) Cells Against Metastatic Cancers or Hematological Malignancies Sensitized to NK-TRAIL Cytotoxicity With Bortezomib
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies : A Pilot Study of Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study : Cardiovascular Reserve Evaluation in Survivors of Transplantation (CREST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma : A Phase I, Open-Label, Dose-escalation, Multicentre Study of KW-2478 Administered as a Single Agent Intravenously in a Consecutive Dosing Schedule in Patients With Relapsed/Refractory Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: 610
Filter aufheben
Thema: Leukemia
Medienart
317
Aufsätze
317
E-Artikel
317
E-Ressourcen
Zeitschriftentitel
317
ClinicalTrials.gov
Thema
610
Leukemia
306
Multiple Myeloma
274
Study Type: Interventional
217
Lymphoma
203
Myelodysplastic Syndromes
175
Neoplasms, Plasma Cell
163
Recruitment Status: Completed
132
Preleukemia
131
Precursor Cell Lymphoblastic Leukemia-Lymphoma
129
Leukemia, Lymphocytic, Chronic, B-Cell
122
Leukemia, Myeloid
116
Myeloproliferative Disorders
116
Syndrome
106
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
105
Leukemia, Lymphoid
102
Leukemia, Myeloid, Acute
84
Neoplasms
84
Phase: Phase 2
82
Phase: Phase 1
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
151
2020-
162
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
317
Englisch
Haven't found what you're looking for?
Wird geladen...